James Tobin

James R.
Tobin is currently Chairman at TransMedics, Inc. and TransMedics Group, Inc. since 2011.
He serves as Independent Director at Globus Medical, Inc. since 2015, Director at Impulse Dynamics NV since 2021, Lead Independent Director at Lyra Therapeutics, Inc. since 2022, and Director at Xenter, Inc. Formerly, Mr. Tobin was President, Chief Executive Officer & Director at Boston Scientific Corp.
from 1999 to 2009; President & Chief Executive Officer at Biogen, Inc. from 1997 to 1999; Director at Creative Biomolecules, Inc. from 1995 to 2000; Director at Applera Corp.
from 1999 to 2008; Independent Director at Curis, Inc. from 2011 to 2015; Director at Medical Simulation Corp.
from 2012 to 2018; Director at CardioDx, Inc. from 2014 to 2017; Director at Aptus Endosystems, Inc. from 2011 to 2015; Independent Director at Chiasma, Inc. from 2015 to 2016; Independent Non-Executive Director at Oxford Immunotec Global Ltd. from 2014 to 2021; Director at Oxford Immunotec Ltd. from 2014 to 2021; Director at Biomedical Sciences Careers Program, Inc.; Director at Applied Biosystems, Inc. from 1999 to 2008; Director at Quest Diagnostics TB LLC from 2014 to 2021; Director at Corindus Vascular Robotics, Inc. from 2018 to 2019; Director at Resolys Bio, Inc.; President & Chief Operating Officer at Baxter International, Inc. from 1972 to 1994; and Principal at US Department of the Navy (District of Columbia) in 1972.
Education includes an MBA from Harvard Business School conferred in 1968 and an undergraduate degree from Harvard College conferred in 1996.